Drug conjugate composition

Details Drug conjugate composition Drug conjugate composition

2008-05-20

2008-05-20

Chan, Christina (Department: 1644)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

C424S193100

Reexamination Certificate

active

10846129

ABSTRACT:
The invention provides a liquid composition and a lyophilized composition comprising a therapeutically effective amount of a conjugate comprising an antibody chemically coupled to a maytansinoid. The invention further provides a method for killing a cell in a human comprising administering to the human either of the compositions such that the antibody binds to the surface of the cell and the cytotoxicity of the maytansinoid is activated, whereby the cell is killed.

REFERENCES:
patent: 3896111 (1975-07-01), Kupchan et al.
patent: 4151042 (1979-04-01), Higashide et al.
patent: 4563304 (1986-01-01), Carlsson et al.
patent: 5208020 (1993-05-01), Chari et al.
patent: 5225539 (1993-07-01), Winter
patent: 5416064 (1995-05-01), Chari et al.
patent: 5475092 (1995-12-01), Chari et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5585089 (1996-12-01), Queen et al.
patent: 5639641 (1997-06-01), Pedersen et al.
patent: 5665357 (1997-09-01), Rose et al.
patent: 5693761 (1997-12-01), Queen et al.
patent: 5714352 (1998-02-01), Jakobovits
patent: 6171586 (2001-01-01), Lam et al.
patent: 6333410 (2001-12-01), Chari et al.
patent: 6340701 (2002-01-01), Chari et al.
patent: 6372738 (2002-04-01), Chari et al.
patent: 6436931 (2002-08-01), Chari et al.
patent: 6441163 (2002-08-01), Chari et al.
patent: 6824780 (2004-11-01), Devaux et al.
patent: 2001/0036923 (2001-11-01), Chari et al.
patent: 2002/0001587 (2002-01-01), Erickson et al.
patent: 2002/0197266 (2002-12-01), Debinski
patent: 2003/0004210 (2003-01-01), Chari et al.
patent: 0 239 400 (1994-08-01), None
patent: 2 188 638 (1987-10-01), None
patent: WO 97/04801 (1997-02-01), None
patent: WO 00/02587 (2000-01-01), None
patent: WO 01/00244 (2001-01-01), None
patent: WO 01/24763 (2001-04-01), None
patent: WO 01/38318 (2001-05-01), None
patent: WO 01/49698 (2001-07-01), None
patent: WO 02/16401 (2002-02-01), None
patent: WO 02/060955 (2002-08-01), None
patent: WO 02/092127 (2002-11-01), None
patent: WO 03/057163 (2003-07-01), None
Carlsson et al.,Biochemical Journal, 173, 723-737 (1978).
Colomer et al.,Cancer Investigation, 19 (1), 49-56 (2001).
Francisco et al.,Blood, 102 (4), 1458-1465 (2003).
Ghetie et al.,Journal of Immunological Methods, 112, 267-277 (1988).
Heider et al.,European Journal of Cancer, 31A (13/14), 2385-2391 (1995).
Ichimura et al.,Journal of Antibiotics, 44 (10), 1045-1053 (1991).
Kupchan et al.,Journal of Medicinal Chemistry, 21 (1), 31-37 (1978).
Liu et al.,Proc. Natl. Acad. Sci, 93, 8618-8623 (1996).
Maloney et al.,Blood, 90 (6), 2188-2195 (1997).
Nadler et al.,Journal of Immunology, 131 (1), 244-250 (1983).
Pedersen et al.,Journal of Molecular Biology, 235 (3), 959-973 (1994).
Reiter et al.,Protein Engineering, 7 (5), 697-704 (1994).
Remillard et al.,Science, 189 (4207), 1002-1005 (1975).
Roguska et al.,Proc. Natl. Acad. Sci., 91, 969-973 (1994).
Sasse et al.,Journal of Antibiotics, 53 (9), 879-885 (2000).
Suzawa et al.,Bioorganic and Medicinal Chemistry, 8, 2175-2184 (2000).
Wang,International Journal of Pharmaceutics, 203, 1-60 (2000).
Welt et al.,Journal of Clinical Oncology, 12 (6), 1193-1203 (1994).
Yoshitake et al.,European Journal of Biochemistry, 101, 395-399 (1979).

Affiliated with

Also associated with

Rating

Drug conjugate composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Drug conjugate composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug conjugate composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3956952